Nuphar Luteum Liquid (S#1162)-Liq 2 X Liquid is a Health Canada–registered human drug (DIN 02189526) held by Total Health Centre, containing Nuphar Luteum. Health Canada lists its status as Cancelled Post Market (status date 05 Aug 2009). Nexara Health has matched 8 registrations of Nuphar Luteum across 1 other regulated market.
Health Canada registration
| DIN | 02189526 |
|---|---|
| Brand name | Nuphar Luteum Liquid (S#1162)-Liq |
| Active ingredient | Nuphar Luteum |
| Strength | 2 X |
| Dosage form | Liquid |
| Route | Oral |
| Company | Total Health Centre |
| Status | Cancelled Post Market — 05 Aug 2009 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Nuphar Luteum registered in other markets
8 registrations of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United States | Nuphar Luteum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Nuphar Luteum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Nuphar Luteum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Nuphar Luteum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Nuphar Luteum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Nuphar Luteum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Nuphar Luteum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Nuphar Luteum | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC |
See every manufacturer of Nuphar Luteum worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Nuphar Luteum Liquid (S#1162)-Liq (DIN 02189526) marketed in Canada?
No. Health Canada lists DIN 02189526 as Cancelled Post Market as of 05 Aug 2009.
Who holds the Canadian licence for this product?
Total Health Centre is the company of record in the Health Canada Drug Product Database.
Is Nuphar Luteum registered outside Canada?
Yes — Nexara Health has matched 8 registrations in 1 other market (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02189526, status date 2009-08-05; national medicine registries: FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02189526, status date 2009-08-05; national medicine registries: FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02189526, status date 2009-08-05; national medicine registries: FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.